
Becton Dickinson & Co
BDXNYSECIK 10795HealthcareFiscal year ends Sep 30
Reports and events: 344 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2022-03-0116:56 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000010795-22-000022 |
| 2022-02-0311:38 ET | 10-Q | Quarterly reportPeriod 2021-12-31 | 0000010795-22-000017 |
| 2022-02-0306:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000010795-22-000014 |
| 2022-01-2614:37 ET | 8-K | 5.07 Shareholder vote results | 0000010795-22-000007 |
| 2021-12-1611:03 ET | DEF 14A | Proxy statementPeriod 2021-12-16 | 0000010795-21-000097 |
| 2021-11-2414:57 ET | 10-K | Annual reportPeriod 2021-09-30 | 0000010795-21-000091 |
| 2021-11-0406:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000010795-21-000083 |
| 2021-10-2206:54 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000010795-21-000079 |
| 2021-10-0408:56 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000010795-21-000073 |
| 2021-09-2716:16 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-21-032587 |
| 2021-08-3006:03 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0000010795-21-000066 |
| 2021-08-1916:26 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-21-028901 |
| 2021-08-1317:18 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-21-028306 |
| 2021-08-1106:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000010795-21-000061 |
| 2021-08-1013:34 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-21-027724 |
| 2021-08-0514:50 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0000010795-21-000057 |
| 2021-08-0511:53 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-21-027063 |
| 2021-08-0506:04 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000010795-21-000054 |
| 2021-07-1207:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-21-212422 |
| 2021-05-0617:24 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-21-016246 |
| 2021-05-0613:08 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0000010795-21-000046 |
| 2021-05-0606:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000010795-21-000044 |
| 2021-04-2606:37 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000010795-21-000039 |
| 2021-02-1217:14 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-21-004715 |
| 2021-02-1117:00 ET | 8-K | 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-21-004377 |
| 2021-02-1021:27 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-21-003992 |
| 2021-02-0416:09 ET | 10-Q | Quarterly reportPeriod 2020-12-31 | 0000010795-21-000029 |
| 2021-02-0406:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000010795-21-000025 |
| 2021-01-2811:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0000010795-21-000019 |
| 2021-01-1207:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000010795-21-000013 |
| 2020-12-1711:03 ET | DEF 14A | Proxy statementPeriod 2020-12-17 | 0000010795-20-000064 |
| 2020-11-2514:21 ET | 10-K | Annual reportPeriod 2020-09-30 | 0000010795-20-000055 |
| 2020-11-1717:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000010795-20-000044 |
| 2020-11-0506:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000010795-20-000040 |
| 2020-10-2216:31 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000010795-20-000036 |
| 2020-10-0511:13 ET | 8-K | 5.03 Amendment to articles or bylaws | 0000010795-20-000032 |
| 2020-08-0615:25 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0000010795-20-000027 |
| 2020-08-0606:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000010795-20-000024 |
| 2020-05-2617:27 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-20-012479 |
| 2020-05-2016:34 ET | 8-K | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-20-012072 |
| 2020-05-1319:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-20-011484 |
| 2020-05-0713:24 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0000010795-20-000019 |
| 2020-05-0706:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000010795-20-000016 |
| 2020-04-3013:37 ET | 8-K | 7.01 Regulation FD disclosure | 0000010795-20-000013 |
| 2020-04-1417:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-20-008843 |
| 2020-04-0217:13 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-20-007843 |
| 2020-03-2320:10 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-20-006481 |
| 2020-02-0616:00 ET | 10-Q | Quarterly reportPeriod 2019-12-31 | 0000010795-20-000010 |
| 2020-02-0606:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000010795-20-000007 |
| 2020-01-3110:51 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000010795-20-000003 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 11, 2026, 03:43 ET. Listed shows no prices and gives no investment advice.